Please try another search
For the six months ended 30 June 2021, Voluntis SArevenues decreased 15% to EUR1.9M. Net loss applicable tocommon stockholders decreased 48% to EUR4.2M. Revenuesreflect Diabetes segment decrease of 55% to EUR314K,Oncology segment decrease of 41% to EUR364K, Switzerlandsegment decrease of 75% to EUR151K, Rest of the Worldsegment decrease of 94% to EUR2K.
Period Ending: | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Total Revenue | 1.89 | 2.96 | 2.23 | 2.16 |
Gross Profit | 1.88 | 2.96 | 2.21 | 2.13 |
Operating Income | -4 | -3.45 | -7.66 | -6.86 |
Net Income | -4.18 | -4.05 | -8.07 | -7.38 |
Period Ending: | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Total Assets | 16.75 | 17.85 | 12.97 | 17.28 |
Total Liabilities | 25.26 | 22.48 | 19.29 | 15.53 |
Total Equity | -8.51 | -4.63 | -6.32 | 1.74 |
Period Ending: | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Period Length: | 6 Months | 0 Months | 6 Months | 12 Months |
Cash From Operating Activities | -3.85 | -1.37 | 1.38 | -12.17 |
Cash From Investing Activities | -0.16 | -0.75 | -0.48 | -2.15 |
Cash From Financing Activities | -0.65 | 8.02 | -1.83 | -0.35 |
Net Change in Cash | -4.65 | 5.89 | -0.93 | -14.66 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review